Single cell heterogeneity in human pluripotent stem cells

키워드

참고문헌 (110)

1. Nichols J, "Naive and primed pluripotent states", Cell Stem Cell, 4, pp.487~492 (2009)
2. Weinberger L, "Dynamic stem cell states : naive to primed pluripotency in rodents and humans", Nat Rev Mol Cell Biol, 17, pp.155~169 (2016)
3. Niwa H, "A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells", Nature, 460, pp.118~122 (2009)
4. Toyooka Y, "Identification and characterization of subpopulations in undifferentiated ES cell culture", Development, 135, pp.909~918 (2008)
5. Wang J, "Primate-specific endogenous retrovirus-driven transcription defines naivelike stem cells", Nature, 516, pp.405~409 (2014)
6. Liu Y, "Multi-omic measurements of heterogeneity in HeLa cells across laboratories", Nat Biotechnol, 37, pp.314~322 (2019)
7. Initiative ISC, "Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage", Nat Biotechnol, 29, pp.1132~1144 (2011)
8. Draper JS, "Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells", Nat Biotechnol, 22, pp.53~54 (2004)
9. Taapken SM, "Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells", Nat Biotechnol, 29, pp.313~314 (2011)
10. Baker D, "Detecting genetic mosaicism in cultures of human pluripotent stem cells", Stem Cell Reports, 7, pp.998~1012 (2016)
11. Närvä E, "High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity", Nat Biotechnol, 28, pp.371~377 (2010)
12. Merkle FT, "Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations", Nature, 545, pp.229~233 (2017)
13. Kucab JE, "A compendium of mutational signatures of environmental agents", Cell, 177, pp.821~836 (2019)
14. Halliwell JA, "Nucleosides rescue replication-mediated genome instability of human pluripotent stem cells", Stem Cell Reports, 14, pp.1009~1017 (2020)
15. Simara P, "DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing", Stem Cell Res Ther, 8, pp.73~ (2017)
16. Vallabhaneni H, "High basal levels of γH2AX in human induced pluripotent stem cells are linked to replication-associated DNA damage and repair", Stem Cells, 36, pp.1501~1513 (2018)
17. Cannan WJ, "Mechanisms and consequences of double-strand DNA break formation in chromatin", J Cell Physiol, 231, pp.3~14 (2016)
18. Zhang J, "Anti-apoptotic mutations desensitize human pluripotent stem cells to mitotic stress and enable aneuploid cell survival", Stem Cell Reports, 12, pp.557~571 (2019)
19. Lamm N, "Genomic instability in human pluripotent stem cells arises from replicative stress and chromosome condensation defects", Cell Stem Cell, 18, pp.253~261 (2016)
20. Ji J, "Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells", Stem Cells, 30, pp.435~440 (2012)
21. Yoshihara M, "Hotspots of de novo point mutations in induced pluripotent stem cells", Cell Reports, 21, pp.308~315 (2017)
22. Rouhani FJ, "Mutational history of a human cell lineage from somatic to induced pluripotent stem cells", PLoS Genet, 12, pp.e1005932~ (2016)
23. Thompson O, "Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions", Nat Commun, 11, pp.1528~ (2020)
24. Milholland B, "Differences between germline and somatic mutation rates in humans and mice", Nat Commun, 8, pp.15183~ (2017)
25. Jang J, "Primary ciliumautophagy-nrf2(pan)axis activation commits human embryonic stem cells to a neuroectoderm fate", Cell, 165, pp.410~420 (2016)
26. Saretzki G, "Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells", Stem Cells, 26, pp.455~464 (2008)
27. Maynard S, "Human embryonic stem cells have enhanced repair of multiple forms of DNA damage", Stem Cells, 26, pp.2266~2274 (2008)
28. Hyka-Nouspikel N, "Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells", Stem Cells, 30, pp.1901~1910 (2012)
29. Luo LZ, "DNA repair in human pluripotent stem cells is distinct from that in non-pluripotent human cells", PLoS One, 7, pp.e30541~ (2012)
30. Adams BR, "Dynamic dependence on ATR and ATM for doublestrand break repair in human embryonic stem cells and neural descendants", PLoS One, 5, pp.e10001~ (2010)
31. Julia, "High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis", Cell Stem Cell, 13, pp.483~491 (2013)
32. Desmarais JA, "Apoptosis and failure of checkpoint kinase 1 activation in human induced pluripotent stem cells under replication stress", Stem Cell Res Ther, 7, pp.17~ (2016)
33. Desmarais JA, "Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress", Stem Cells, 30, pp.1385~1393 (2012)
34. Madden DT, "Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members", PLoS One, 6, pp.e28530~ (2011)
35. Dumitru R, "Human embryonic stem cells have constitutively active Bax at the golgi and are primed to undergo rapid apoptosis", Molecular Cell, 46, pp.573~583 (2012)
36. Catalina P, "Human ESCs predisposition to karyotypic instability : is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?", Molecular Cancer, 7, pp.76~ (2008)
37. Imreh MP, "In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells", J Cell Biochem, 99, pp.508~516 (2006)
38. Ben-David U, "Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells", Nat Commun, 5, pp.4825~ (2014)
39. Chambers I, "Nanog safeguards pluripotency and mediates germline development", Nature, 450, pp.1230~1234 (2007)
40. Darr H, "Overexpression of NANOG in human ES cells enables feederfree growth while inducing primitive ectoderm features", Development, 133, pp.1193~1201 (2006)
41. Korkola JE, "Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13. 31, is associated with in vivo differentiation of human male germ cell tumors", Cancer Res, 66, pp.820~827 (2006)
42. Rodriguez S, "Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p)and amplification at 12p11. 2–p12. 1", Oncogene, 22, pp.1880~1891 (2003)
43. Avery S, "BCL-XL mediates the strong selective advantage of a 20q11. 21 amplification commonly found in human embryonic stem cell cultures", Stem Cell Reports, 1, pp.379~386 (2013)
44. Markouli C, "Gain of 20q11. 21 in human pluripotent stem cells impairs TGF-β-dependent neuroectodermal commitment", Stem Cell Reports, 13, pp.163~176 (2019)
45. Jo HY, "Functional in vivo and in vitro effects of 20q11. 21 genetic aberrations on hPSC differentiation", Sci Rep, 10, pp.18582~ (2020)
46. Blum B, "The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells", Nat Biotechnol, 27, pp.281~287 (2009)
47. Lee CT, "Functional consequences of 17q21. 31", WNT3-WNT9B amplification in hPSCs with respect to neural differentiation, 2015, pp.10, 616~632
48. Jain AK, "p53 : emerging roles in stem cells, development and beyond", Development, 145, pp.dev158360~ (2018)
49. Suzuki MM, "DNA methylation landscapes : provocative insights from epigenomics", Nat Rev Genet, 9, pp.465~476 (2008)
50. Hackett JA, "DNA methylation dynamics during the mammalian life cycle", Philos Trans R Soc Lond B Biol Sci, 368, pp.20110328~ (2013)
51. Messerschmidt DM, "DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos", Genes Dev, 28, pp.812~828 (2014)
52. Liao J, "Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells", Nat Genet, 47, pp.469~478 (2015)
53. Bock C, "Reference maps of human ES and iPS cell variation enable highthroughput characterization of pluripotent cell lines", Cell, 144, pp.439~452 (2011)
54. Kristopher, "Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives", Cell Stem Cell, 10, pp.620~634 (2012)
55. Calvanese V, "Cancer genes hypermethylated in human embryonic stem cells", PLoS One, 3, pp.e3294~ (2008)
56. Weissbein U, "Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells", PLoS Genet, 13, pp.e1006979~ (2017)
57. Roost MS, "DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells", Nat Commun, 8, pp.908~ (2017)
58. Bar-Nur O, "Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells", Cell Stem Cell, 9, pp.17~23 (2011)
59. Bartolomei MS, "Mammalian genomic imprinting", Cold Spring Harb Perspect Biol, 3, pp.a002592~a002592 (2011)
60. McGrath J, "Completion of mouse embryogenesis requires both the maternal and paternal genomes", Cell, 37, pp.179~183 (1984)
61. Surani MAH, "Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis", Nature, 308, pp.548~550 (1984)
62. Lim DH, "Genomic imprinting syndromes and cancer", Adv Genet, 70, pp.145~175 (2010)
63. Weksberg R, "Imprinted genes and human disease", Am J Med Genet C Semin Med Genet, 154C, pp.317~320 (2010)
64. Yamazawa K, "Uniparental disomy and human disease : An overview", Am J Med Genet C Semin Med Genet, 154C, pp.329~334 (2010)
65. Initiative TISC, "Characterization of human embryonic stem cell lines by the International Stem Cell Initiative", Nat Biotechnol, 25, pp.803~816 (2007)
66. Rugg-Gunn PJ, "Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines", Hum Mol Genet, 16, pp.R243~R251 (2007)
67. Johannesson B, "Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors", Cell Stem Cell, 15, pp.634~642 (2014)
68. Ma H, "Abnormalities in human pluripotent cells due to reprogramming mechanisms", Nature, 511, pp.177~183 (2014)
69. Pick M, "Clone-and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells", Stem Cells, 27, pp.2686~2690 (2009)
70. Thorold, "Molecular criteria for defining the naive human pluripotent state", Cell Stem Cell, 19, pp.502~515 (2016)
71. William, "Naive human pluripotent cells feature a methylation landscape devoid of blastocyst or germline memory", Cell Stem Cell, 18, pp.323~329 (2016)
72. Bar S, "Large-scale analysis of loss of imprinting in human pluripotent stem cells", Cell Rep, 19, pp.957~968 (2017)
73. Jelinic P, "Loss of imprinting and cancer", J Pathol, 211, pp.261~268 (2007)
74. Leick MB, "Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer", Am J Stem Cells, 1, pp.59~74 (2011)
75. Davies W, "Imprinted gene expression in the brain", Neurosci Biobehav Rev, 29, pp.421~430 (2005)
76. Lyon MF, "Gene Action in the X-chromosome of the mouse(Mus musculus L.)", Nature, 190, pp.372~373 (1961)
77. Petropoulos S, "Singlecell RNA-Seq reveals lineage and X chromosome dynamics in human preimplantation embryos", Cell, 165, pp.1012~1026 (2016)
78. Moreira de Mello JC, "Early X chromosome inactivation during human preimplantation development revealed by single-cell RNA-sequencing", Sci Rep, 7, pp.10794~ (2017)
79. Bruck T, "Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells", Stem Cell Research, 6, pp.187~193 (2011)
80. Dvash T, "Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells", PLoS One, 5, pp.e11330~ (2010)
81. Patel S, "Human embryonic stem cells do not change their X inactivation status during differentiation", Cell Rep, 18, pp.54~67 (2017)
82. Sahakyan A, "Human naive pluripotent stem cells model X chromosome dampening and X inactivation", Cell Stem Cell, 20, pp.87~101 (2017)
83. Shen Y, "X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations", Proc Natl Acad Sci U S A, 105, pp.4709~4714 (2008)
84. Silva SS, "X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells", Proc Natl Acad Sci U S A, 105, pp.4820~4825 (2008)
85. Vallot C, "XACT noncoding RNA competes with XIST in the control of X chromosome activity during human early development", Cell Stem Cell, 20, pp.102~111 (2017)
86. Lengner CJ, "Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations", Cell, 141, pp.872~883 (2010)
87. Geens M, "Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture", Mol Hum Reprod, 22, pp.285~298 (2016)
88. Becker KA, "Selfrenewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase", J Cell Physiol, 209, pp.883~893 (2006)
89. Singh AM, "The cell cycle and myc intersect with mechanisms that regulate pluripotency and reprogramming", Cell Stem Cell, 5, pp.141~149 (2009)
90. Calder A, "Lengthened G1 phase indicates differentiation status in human embryonic stem cells", Stem Cells Dev, 22, pp.279~295 (2013)
91. Sakaue-Sawano A, "Visualizing spatiotemporal dynamics of multicellular cell-cycle progression", Cell, 132, pp.487~498 (2008)
92. Pauklin S, "The cell-cycle state of stem cells determines cell fate propensity", Cell, 155, pp.135~147 (2013)
93. Kevin, "Deterministic restriction on pluripotent state dissolution by cell-cycle pathways", Cell, 162, pp.564~579 (2015)
94. Pauklin S, "Initiation of stem cell differentiation involves cell cycledependent regulation of developmental genes by cyclin D", Genes Dev, 30, pp.421~433 (2016)
95. Tahiliani M, "Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1", Science, 324, pp.930~935 (2009)
96. Amar, "Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells", Stem Cell Reports, 1, pp.532~544 (2013)
97. Jang J, "Control over single-cell distribution of G1 lengths by WNT governs pluripotency", PLoS Biol, 17, pp.e3000453~ (2019)
98. Rossant J, "New insights into early human development : lessons for stem cell derivation and differentiation", Cell Stem Cell, 20, pp.18~28 (2017)
99. Thomson JA, "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)
100. Warmflash A, "A method to recapitulate early embryonic spatial patterning in human embryonic stem cells", Nat Methods, 11, pp.847~854 (2014)
101. Peerani R, "Niche-mediated control of human embryonic stem cell self-renewal and differentiation", EMBO Rep, 26, pp.4744~4755 (2007)
102. Etoc F, "A Balance between secreted inhibitors and edge sensing controls gastruloid self-organization", Dev Cell, 39, pp.302~315 (2016)
103. Fleming TP, "ART and the Human Blastocyst", pp.91~102 (2001), Springer
104. Bedzhov I, "Self-organizing properties of mouse pluripotent cells initiate morphogenesis upon implantation", Cell, 156, pp.1032~1044 (2014)
105. Kallas-Kivi A, "The role of integrin β1 in the heterogeneity of human embryonic stem cells culture", Biol, 7, pp.bio034355~ (2018)
106. Xu C, "Feeder-free growth of undifferentiated human embryonic stem cells", Nat Biotechnol, 19, pp.971~974 (2001)
107. Toh YC, "Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation", Biomaterials, 50, pp.87~97 (2015)
108. Shelley, "Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells", Stem Cell Reports, 2, pp.881~895 (2014)
109. Nakanishi M, "Human pluripotency is initiated and preserved by a unique subset of founder cells", Cell, 177, pp.910~924 (2019)
110. Jeongwoo Lee, "Single-cell multiomics: technologies and data analysis methods", Experimental and Molecular Medicine, 52, pp.1~15 (2020), 생화학분자생물학회[DOI]

관련 논문AI추천